CD5L Inhibits Allergic Airway Inflammation by Lysophosphatidylcholine-Induced ILC2 Apoptosis
Antioxidants & Redox Signaling · 2026
DOI: 10.1177/15230864251406294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2026. Verfasst von Yan Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University…. Hauptthemen laut MEDLINE: Apoptosis, Lysophosphatidylcholines, Lymphocytes, Asthma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Chongqing Yuzhong District Science and Technology Bureau, Natural Science Foundation of Chongqing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Group 2 innate lymphoid cells (ILC2s) play key roles in allergic asthma development. We have previously discovered that CD5 antigen-like protein (CD5L) can inhibit allergic airway inflammation. In this study, we investigate the effect of CD5L on ILC2s and the underlying mechanism.
Results
Our findings demonstrated that CD5L suppresses allergic airway inflammation by inhibiting ILC2s. CD5L inhibited NF-κB, MAPK, and PI3K-AKT pathways in ILC2s, thus reducing interleukin (IL)-5 and IL-13 production. CD5L increased the level of lysophosphatidylcholine (lysoPC) in ILC2s through the transforming growth factor beta (TGF-β) signaling pathway. The elevated lysoPC further induced reactive oxygen species (ROS) production in ILC2s, and the increased ROS fed back to increase the level of lysoPC. The accumulated ROS induced ILC2 apoptosis. The scavenger receptor CD36 mediated the inhibitory effect of CD5L on ILC2s and allergic airway inflammation. Finally, CD5L was shown to be potential therapeutic for allergic asthma. Innovation: This study is the first to demonstrate that CD5L suppresses allergic airway inflammation by inhibiting ILC2 responses. It is the initial discovery that CD5L promotes ILC2 apoptosis, whereas CD5L was previously recognized as an apoptosis inhibitor. The regulation of TGF-β signaling pathway on lysoPC is demonstrated for the first time.
Conclusion
This study demonstrated that CD5L inhibits ILC2 activation and induces ILC2 apoptosis, thereby suppressing allergic airway inflammation. CD5L can serve as a novel therapeutic strategy for allergic asthma. Antioxid. Redox Signal. 44, 393–409.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Laboratory Medicine, The First People's Hospital of Zunyi City (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China.
- Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Clinical Laboratory, Children's Hospital of Chongqing Medical University, Chongqing, China.
- Department of Blood Transfusion, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Förderung
- Chongqing Yuzhong District Science and Technology Bureau
- Natural Science Foundation of Chongqing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Chen, T., Qin, Y., Lin, M., Yao, S., Sun, X., Jia, Y., Yang, X., Kong, Q., Zhang, M., Zhang, X., Yin, Y., & Xu, W. (2026). CD5L Inhibits Allergic Airway Inflammation by Lysophosphatidylcholine-Induced ILC2 Apoptosis. Antioxidants & Redox Signaling. https://doi.org/10.1177/15230864251406294
Vancouver
Wang Y, Chen T, Qin Y, Lin M, Yao S, Sun X, et al. CD5L Inhibits Allergic Airway Inflammation by Lysophosphatidylcholine-Induced ILC2 Apoptosis. Antioxidants & Redox Signaling. 2026. doi:10.1177/15230864251406294
BibTeX
@article{Wang2026,
author = {Wang, Yan and Chen, Te and Qin, Yaqi and Lin, Meilian and Yao, Shifei and Sun, Xiaoyu and Jia, Yanjun and Yang, Xiaoliang and Kong, Qingxiang and Zhang, Minghao and Zhang, Xuemei and Yin, Yibing and Xu, Wenchun},
title = {CD5L Inhibits Allergic Airway Inflammation by Lysophosphatidylcholine-Induced ILC2 Apoptosis},
journal = {Antioxidants & Redox Signaling},
year = {2026},
doi = {10.1177/15230864251406294}
}
EUVIMED